Sasi Sreethish, Hamed Manal Mahmoud Mohamed, Abdel Hadi Hamad Elnil Abdelgabar, Goravey Wael, Ibrahim Emad, Abid Fatma Ben, Doiphode Sanjay, Wilson Godwin, Kashaf Adila Shaukat Ali, Al-Maslamani Muna, Al-Khal Abdullatif
Infectious Diseases Division, Department of Medicine, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Division of Microbiology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.
Infect Drug Resist. 2025 May 11;18:2439-2449. doi: 10.2147/IDR.S501554. eCollection 2025.
complex (CKC), including , and , has been implicated in breast abscesses and granulomatous mastitis, presenting diagnostic and therapeutic challenges. Its lipophilic nature and association with specific populations necessitate targeted investigations.
This retrospective study was conducted at Hamad Medical Corporation, Qatar, including all CKC isolates from breast tissue collected between October 2016 and March 2024. Data from electronic medical records were collected and anonymized. Microbiological analysis involved standard culture techniques, Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) for identification, and antibiotic susceptibility testing per Clinical and Laboratory Standards Institute (CLSI) standards. Statistical methods included descriptive analyses, Pearson's correlation, and relative risk calculations.
Among 34 isolates, 31 were from breast tissue of pre-menopausal women, predominantly obese or overweight, with a median age of 33 years. Breast abscesses were typically unilateral, associated with axillary lymphadenopathy, and varied in size and complexity. Recurrence within six months occurred in 58% of cases. Prolonged antimicrobial therapy and, in some cases, surgical intervention were necessary. Most isolates were sensitive to vancomycin, linezolid, and rifampicin, but resistance to penicillin and daptomycin was noted.
CKC is an emerging pathogen in breast abscesses, requiring precise diagnostic approaches and individualized treatment strategies. Advanced genomic tools are recommended for species differentiation and resistance monitoring. Ongoing research is essential to optimize management and address rising antimicrobial resistance.
包括[具体菌种1]、[具体菌种2]和[具体菌种3]在内的复杂苛养菌(CKC)与乳腺脓肿和肉芽肿性乳腺炎有关,带来了诊断和治疗方面的挑战。其亲脂性以及与特定人群的关联需要有针对性的研究。
本回顾性研究在卡塔尔哈马德医疗公司进行,纳入了2016年10月至2024年3月期间从乳腺组织中分离出的所有CKC菌株。从电子病历中收集数据并进行匿名化处理。微生物学分析包括标准培养技术、用于鉴定的基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)以及按照临床和实验室标准协会(CLSI)标准进行的抗生素敏感性测试。统计方法包括描述性分析、Pearson相关性分析和相对风险计算。
在34株分离菌株中,31株来自绝经前女性的乳腺组织,这些女性大多肥胖或超重,中位年龄为33岁。乳腺脓肿通常为单侧,伴有腋窝淋巴结肿大,大小和复杂性各异。58%的病例在六个月内复发。需要延长抗菌治疗时间,在某些情况下还需要手术干预。大多数分离菌株对万古霉素、利奈唑胺和利福平敏感,但对青霉素和达托霉素存在耐药情况。
CKC是乳腺脓肿中一种新出现的病原体,需要精确的诊断方法和个体化的治疗策略。建议使用先进的基因组工具进行菌种鉴别和耐药性监测。持续的研究对于优化管理和应对不断上升的抗菌药物耐药性至关重要。